{"name":"Jennifer Taylor-Cousar","slug":"jennifer-taylor-cousar","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Elexacaftor-tezacaftor-ivacaftor exposure","genericName":"Elexacaftor-tezacaftor-ivacaftor exposure","slug":"elexacaftor-tezacaftor-ivacaftor-exposure","indication":"Cystic fibrosis","status":"phase_2"}]}],"pipeline":[{"name":"Elexacaftor-tezacaftor-ivacaftor exposure","genericName":"Elexacaftor-tezacaftor-ivacaftor exposure","slug":"elexacaftor-tezacaftor-ivacaftor-exposure","phase":"phase_2","mechanism":"CFTR potentiator","indications":["Cystic fibrosis"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQblpvdGtUY0ljdnZuTUhFZ3lKTHBjV1ZoQkZxSnBISUs4ekRScXVRS0sxVlJmZFV1NUh3XzU4NG55NGtfSFJHdFdGWkh6dDBWLWZKQjRXSkVQYkxuU054R0JYbmJQUXBVNFpzYWlWSU1rZkEzaDJwWXNGQTQzV2ZUcmVuNnUxbHh2N3FTR1RyNXQwc1NvYkJydU9SUzU3VldVaW43NDRBc1Rvcm83RW1fTHBwY0pJTU4wWW5YVG9vQ1Nudw?oc=5","date":"2023-06-13","type":"pipeline","source":"Healio","summary":"Addressing disparities in diagnosing cystic fibrosis in diverse populations - Healio","headline":"Addressing disparities in diagnosing cystic fibrosis in diverse populations","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxPTFc2cXFieC1DVE9iMm9vRFI0TWJPYm91aHRkX1JhbjhZeFVQWE5QV3piMjdtenl4VFZvWFNlb3dNS2JJdXR4OGRPSEM2V1MtWG0zZmdPaThvZTZUYXlCTEJZUjB2MW84c1htYTRvYkVSSkl5dEplRGlUcWREYlZ3TW5ZVG1HRW9iMlNwNGw3LTNEdGRDRk9GVEgwalBoNjhxcUhVekt2Z19CVlk?oc=5","date":"2023-02-28","type":"pipeline","source":"National Geographic","summary":"Cystic fibrosis often goes under-diagnosed—unless you’re white - National Geographic","headline":"Cystic fibrosis often goes under-diagnosed—unless you’re white","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE1VZFhmMllDYVdiRjBBcDdqdWhzbXp4ZURoSmVEY1RrVTZoUUc0UHN4SjlmTWR1cXNvRnpEcTJ4SXg5N3FfSlY4ZFNRNWgxQng1S1RUOXVfRno0WGYzTmdldW1mWGFhTmpXN09hNlRIU2o?oc=5","date":"2022-08-01","type":"pipeline","source":"5280 - Denver's Mile High Magazine","summary":"Inside Colorado’s Battle Against Rare Diseases - 5280 - Denver's Mile High Magazine","headline":"Inside Colorado’s Battle Against Rare Diseases - 5280 - Denver's Mile High Magazine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTFBESW9zemswWjBQdVh0Q2VBRDBpWVNpOER4eF9IZUpfdVN1cVVjUUMwcDRIZWY2VkNPN3JjLTJZc3BhMkRWUEtkXzE2TjliemNqc1FCMDFQVU9UZGcxcGMwVQ?oc=5","date":"2019-10-31","type":"pipeline","source":"NEJM","summary":"Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele - NEJM","headline":"Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBfWGt0clJPblQ3SUlHWE5VVmxoN3l2cm5BLXpTM0NidzhJZVYzaTRKTGVOOUREZkVuc3R5Yi1Eb0pMY3cxWXlFS0YxZlg4Q3FXd2JJQjR3ekpEQUMyOVZv?oc=5","date":"2018-05-02","type":"pipeline","source":"NEJM","summary":"Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del - NEJM","headline":"Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE4wTFJlRkVTUVdmWnJfWEJpU2NxbFJTUHdPaG43Y1FWNzZmWU1uMl84WFE5NFYwSDFmcnVYdnAwaFVNVXlEX2ZBSGlNbVRNOGFjTFFzLUNBdjdtUkx3N05VTkdwcmF0dUlvaGFKX2Vja0ViQ052TTJhUTVR?oc=5","date":"2018-02-01","type":"pipeline","source":"pharmaphorum","summary":"New Vertex drugs could help 90% of cystic fibrosis patients - pharmaphorum","headline":"New Vertex drugs could help 90% of cystic fibrosis patients","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTFBQVXdobk1NdjQzdVo1cmJSYTRQcXlncE13cnZvNy04WUc0TGdCM2RpSk9QSnAzb2xZejk2TjFHTms0QnRoeWI5a3pvTDBRdENaY3haTUFVZHpOM2J4RjY3Mg?oc=5","date":"2017-11-03","type":"pipeline","source":"NEJM","summary":"Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del - NEJM","headline":"Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPdk9YS1JiYkRvV0tvYmVHNHN1T2cwWkpSREtQaXBVUU40WWVvSk1JWl96VjJZdGliV25BU1h6bDNUc0c0QV9ZRzBWYmZGVmxCb19xb19QMEFGZ2s2UGViSWdYbHRLZkxRZ2Z0cVl6UVVGemhOUS1XSlF1MUtOTzhza2RiQXUzVHpYV0FJVzdtVUlrTzY3N2RqYk1n?oc=5","date":"2011-04-13","type":"pipeline","source":"CBS News","summary":"Nebulizer Helps Denver Zoo Orangutan Live A Better Life - CBS News","headline":"Nebulizer Helps Denver Zoo Orangutan Live A Better Life","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}